Skip to main content
Premium Trial:

Request an Annual Quote

Fluidigm’s Singapore Manufacturing Facility Reaches Full Throttle Ahead of Schedule

NEW YORK (GenomeWeb News) – Fluidigm yesterday said that its manufacturing facility in Singapore has begun working at full process ahead of schedule.
 
The facility, which opened its doors less than one year ago, was to reach this level by the end of 2006, a Fluidigm spokesperson said.
 
The facility manufactures BioMark dynamic arrays, among other products, which are integrated fluidic circuits that are designed to increase qPCR efficiency. Fluidigm will sell these products to study genetic and protein biomarkers.
 
Other chips currently being developed “address multi-step processes on a nanovolume scale, including synthesis of imaging probes used in positron emission tomography and the preparation of nucleic acids for analysis,” Fluidigm said in a statement.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more